Skip to main content

Table 3 Outcomes of patients with ARDS with and without comorbidities

From: Presence of comorbidities alters management and worsens outcome of patients with acute respiratory distress syndrome: insights from the LUNG SAFE study

Parameter

No comorbidities (n = 1121)

Any comorbidities (n = 1692)*

Chronic respiratory impairment (n = 631)

Congestive heart failure (n = 290)

Chronic renal failure (n = 286)

Chronic liver failure (n = 112)

Immune incompetence

(n = 584)

Diabetes (n = 613)

Invasive ventilation-free days, median (IQR), days

        

 All patients, N = 2377

15 (0–23)

5 (0–23)*

15 (0–23)

4 (0–22)*

0 (0–23)*

0 (0–19)*

0 (0–22)*

10 (0–23)*

 Survivors, N = 1539

20 (13–25)

21 (16–25)*

22 (16–25)*

22 (16–25)

22 (12–25)

22 (20–25)

22 (16–25)

21 (15–25)

Duration of invasive mechanical ventilation, median (IQR), days

        

 All patients, N = 2377

8 (4–16)

8 (4–14)

7 (4–14)

8 (3–14)

8 (4–18)

7 (3–12)*

8 (4–14)

8 (4–15)

 Surviving patients, N = 1539

9 (4–16)

8 (4–14)*

7 (4–13)*

8 (4–13)

7 (4–17)

7 (4–9)

7 (4–13)

8 (4–14)

ARDS criteria, n (%)

        

 Still present 24 h after diagnosis N = 1611

683 (76.1)

928 (76.3)

334 (75.4)

147 (73.9)

147 (74.2)

64 (76.2)

327 (77.9)

346 (76.5)

 Resolved ARDS, N = 503

215 (23.9)

288 (23.7)

109 (24.6)

52 (26.1)

51 (25.8)

20 (23.8)

93 (22.1)

106 (23.5)

Duration of ICU Stay, median (IQR), days

        

 All patients, N = 2813

11 (5–20)

9 (5–17)*

9 (4–16)*

9 (4–17)*

9 (5–20)

8 (4–15)*

10 (5–17)*

10 (5–18)

 Survivors, N = 1849

12 (6–21)

10 (6–18)*

9 (5–17)*

10 (5–18)*

9 (6–19)*

10 (6–16)

10 (6–17)*

10 (6–19)

Duration of hospital stay, median (IQR), days

        

 All patients, N = 2813

18 (9–35)

16 (8–29)*

16 (8–27)*

14 (7–25)*

16 (8–28)*

10 (4–23)*

17 (8–29)*

16 (9–31)

 Survivors, N = 1695

23 (13–40)

22 (12–38)

19 (11–33)*

20 (11–35)*

22 (13–43)

26 (16–56)

24 (15–40)

21 (13–40)

ICU mortality, No. (%)

303 (27.0)

661 (39.1)*

209 (33.1)*

120 (41.4)*

113 (39.5)*

75 (67.0)*

266 (45.5)*

210 (34.3)*

Hospital mortality, No. (%)

347 (31.0)

762 (45.3)*

242 (38.7)*

135 (46.9)*

138 (48.4)*

81 (72.3)*

304 (52.4)*

254 (41.6)*

Limitation of life-sustaining measures, n (%)

209 (18.6)

493 (29.1)*

162 (25.7)*

87 (30.0)*

83 (29.0)*

49 (43.8)*

195 (33.4)*

158 (25.8)

 Withhold

165 (15.4)

408 (25.3)*

131 (21.6)*

70 (24.9)*

65 (23.9)*

43 (39.8)*

158 (28.6)*

142 (24.2)*

 Withdraw

336 (20.9)

149 (13.9)*

113 (18.8)*

57 (20.7)*

64 (23.3)*

39 (35.8)*

129 (23.6)*

107 (18.2)*

  1. Test used for continuous variables: Wilcoxon rank sum (all variables are not normally distributed); for categorical variables: Chi square. Missing information on hospital mortality in 9 patients. *The group “Any comorbidities” includes less patients than the sum of the single comorbidities as patients could have more than 1 comorbidity
  2. * < 0.05 versus No comorbidities